Literature DB >> 9347518

Polyclonal T-cell responses to Plasmodium falciparum gametocytes in malaria nonexposed donors.

M R Goodier1, G A Targett.   

Abstract

Human peripheral blood T-cells mount vigorous proliferative responses to asexual stage parasites of P. falciparum regardless of whether the donor has been exposed to the parasite. Here using highly purified P. falciparum gametocytes we show that the same is also true for this stage of the parasite. Gametocytes, like immature trophozoites, preferentially activate CD4+ T cells gamma delta T-cell activation, commonly observed in response to mature schizonts or supernatants from asexual-stage cultures, does not occur. Furthermore, the CD4+ T-cell receptor variable region (TCRV beta) usage to those stimulated by asexual parasites and there is no preferential usage of TCRV beta elements. The CD4+ T-cell precursor frequencies for gametocyte and asexual trophozoite responses are remarkably similar. 'Cross-reactivity' of gametocytes and asexual stage responses was confirmed by selective depletion of cells responding to particular stages of the parasite using the cytostatic drug cytosine arabinoside (Ara-C). These results suggest that the CD4+ T-cell responses from malaria non-exposed donors are common to gametocytes and asexual trophozoites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9347518     DOI: 10.1046/j.1365-3024.1997.d01-238.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  9 in total

1.  Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.

Authors:  C E Contreras; I N Ploton; R F Siliciano; C L Karp; R Viscidi; N Kumar
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

2.  The effect of partial host immunity on the transmission of malaria parasites.

Authors:  A Buckling; A F Read
Journal:  Proc Biol Sci       Date:  2001-11-22       Impact factor: 5.349

3.  Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity.

Authors:  Jiraprapa Wipasa; Lucy Okell; Supachai Sakkhachornphop; Chaisuree Suphavilai; Kriangkrai Chawansuntati; Witaya Liewsaree; Julius C R Hafalla; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

4.  A whole parasite transmission-blocking vaccine for malaria: an ignored strategy.

Authors:  Michael F Good; Stephanie K Yanow
Journal:  Emerg Top Life Sci       Date:  2017-12-22

Review 5.  γδ T Cells in Antimalarial Immunity: New Insights Into Their Diverse Functions in Protection and Tolerance.

Authors:  Kathleen W Dantzler; Prasanna Jagannathan
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

Review 6.  Immune Responses to the Sexual Stages of Plasmodium falciparum Parasites.

Authors:  Jonas A Kengne-Ouafo; Colin J Sutherland; Fred N Binka; Gordon A Awandare; Britta C Urban; Bismarck Dinko
Journal:  Front Immunol       Date:  2019-02-11       Impact factor: 7.561

Review 7.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

Review 8.  HIV-1 Impact on Malaria Transmission: A Complex and Relevant Global Health Concern.

Authors:  Ashleigh Roberds; Emily Ferraro; Shirley Luckhart; V Ann Stewart
Journal:  Front Cell Infect Microbiol       Date:  2021-04-12       Impact factor: 5.293

9.  A Unique Subset of γδ T Cells Expands and Produces IL-10 in Patients with Naturally Acquired Immunity against Falciparum Malaria.

Authors:  Tomoyo Taniguchi; Kaiissar Md Mannoor; Daisuke Nonaka; Hiromu Toma; Changchun Li; Miwako Narita; Viengxay Vanisaveth; Shigeyuki Kano; Masuhiro Takahashi; Hisami Watanabe
Journal:  Front Microbiol       Date:  2017-07-19       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.